{
    "organizations": [],
    "uuid": "9a057e1eb7c445bb5759a3c7eda0a2eedad26576",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-genomic-health-expands-offering-to/brief-genomic-health-expands-offering-to-prostate-cancer-patients-with-launch-of-oncotype-dx-ar-v7-nucleus-detect-test-to-predict-treatment-response-in-metastatic-disease-idUSFWN1QG109",
    "ord_in_thread": 0,
    "title": "BRIEF-Genomic Health Expands Offering To Prostate Cancer Patients With Launch Of Oncotype DX AR-V7 Nucleus Detect Test To Predict Treatment Response In Metastatic Disease",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 26 (Reuters) - Genomic Health Inc:\n* GENOMIC HEALTH EXPANDS OFFERING TO PROSTATE CANCER PATIENTS WITH LAUNCH OF ONCOTYPE DX® AR-V7 NUCLEUS DETECT™ TEST TO PREDICT TREATMENT RESPONSE IN METASTATIC DISEASE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-26T21:12:00.000+02:00",
    "crawled": "2018-02-27T15:05:26.038+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "genomic",
        "health",
        "inc",
        "genomic",
        "health",
        "expands",
        "offering",
        "prostate",
        "cancer",
        "patient",
        "launch",
        "oncotype",
        "nucleus",
        "test",
        "predict",
        "treatment",
        "response",
        "metastatic",
        "disease",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}